Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Medical Condition: Severe COVID-19 pneumonia MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+COVID-19+pneumonia+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Pneumonia%2C+Viral%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+COVID-19+pneumonia+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Pneumonia%2C+Viral%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+COVID-19+pneumonia+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10035737Term%3A+Pneumonia+viralSystem+Organ+Class%3A+10021881+-+Infections+and+infestations%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Pneumonia%2C+Viral%22&type=Subject
PubPharm (14)
1
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
Tocilizumab plus background therapy versus placebo plus background therapy in patients with severe COVID-19 pneumonia. : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Severe COVID-19 pneumonia MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Medienart
14
Aufsätze
14
E-Artikel
14
E-Ressourcen
Zeitschriftentitel
14
WHO International Clinical Trials Registry Plat...
Thema
14
610
Medical Condition: Severe COVID-19 pneumonia Me...
14
Study Type: Interventional
12
Recruitment Status: Not yet recruiting
8
Phase: Phase 3
6
Phase: Phase 2
2
Recruitment Status: Authorised-recruitment may ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2022
2
2021
10
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
14
Englisch
Haven't found what you're looking for?
Wird geladen...